Objective We sought to determine the value of electrocardiographic right ventricular hypertrophy (ECG-RVH) in pulmonary hypertension (PH) patients with right ventricular systolic dysfunction defined by cardiac magnetic resonance (CMR-RVSD). Patients A total of 31 consecutive patients with PH with a mean pulmonary arterial pressure of >25 mmHg underwent both ECG and CMR studies. Patients were divided into 2 groups according to the presence of RVSD, defined as a RV ejection fraction <35%. Logistic regression modeling was performed to define the association between ECG-RVH and CMR-RVSD. Results About half of the patients had RVSD (n=15 ; 48%). The R to S wave ratio (p=0.01) or incidence of qR pattern (p=0.002) in lead V1 was significantly greater in patients with PH complicated by RVSD than in those without RVSD. These 2 patterns were significant predictors of RVSD [odds ratio (OR), 19.3 for qR; OR, 14.0 for R/S>1] and when each of these ECG findings was assigned with a point proportional to OR (score of 2 for qR in lead V1 and score of 1 for R/S>1 in lead V1), the incidence of RVSD increased by the total ECG score. Conclusion The combination of ECG-RVH findings, especially in lead V1, predicts the presence of RVSD defined by CMR. ECG might be a useful tool for estimating the presence of RVSD in patients with PH.
Introduction
Pulmonary hypertension (PH) is a life-threatening condition characterized by elevated blood pressure and resistance to pulmonary blood flow in the pulmonary vessels. In patients with PH, progressive right ventricular systolic dysfunction (RVSD) is a major end-organ comorbidity that can lead to RV failure. Studies have shown that RVSD detected by either direct hemodynamic measurement or overt clinical signs was associated with increased mortality (1, 2). Therefore, accurate measurement of the RV ejection fraction (RVEF) and detection of the early global or regional functional systolic abnormalities of baseline RV function is an essential part of the workup for patients with PH.
However, early RVSD might be difficult to detect on clinical examination. As a result, electrocardiogram (ECG) is mandated for this purpose (3) . However, despite its inexpensiveness and wide availability, RVEF measured by echocardiography can only be indirectly estimated from measurements acquired in 2 dimensions. The anatomy of the RV is unique and complex; therefore, detection of RVSD is dependent on an experienced operator (4), or it is only detected in patients in whom RV failure is already clinical overt (5) .
Cardiac magnetic resonance (CMR) imaging has recently Figure  1A . Endocardial borders were manually traced at end-systole and end-diastole to calculate the RV volume and ejection fraction.
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emerged as the new gold standard for the assessment of RV in PH and other diseases. This technique allows for image acquisition in any plane and at almost any angle, allowing direct measurement of RVEF and RV volumes. In addition, ECG is a universally available, easy to operate, cost-saving diagnostic tool for various cardiovascular disorders, and it can define RV hypertrophy (RVH) with very high specificity (6, 7). We sought to determine the association between various ECG-RVH criteria and the presence of RVSD determined by CMR. Patients with RVSD are known to have impaired prognoses, and validating the RVH criteria among patients with PH would clarify the role of ECG in identifying highrisk patients.
Materials and Methods

Study population
We performed both an ECG and CMR imaging in 31 consecutive patients with PH who were referred to Keio University Hospital, Tokyo, Japan, from October 2007 to July 2008. PH was defined as pulmonary artery mean pressure >25 mmHg by cardiac catheterization. The causes of PH in the patients in this study were as follows: 24 had pulmonary arterial hypertension (PAH) (20 had idiopathic PAH; IPAH, 3 had autoimmune disease, and 1 had an atrial septal defect) and 7 had chronic thromboembolic PH (CTEPH). Patients were divided into 2 groups according to the presence or absence of RVSD, which was defined as RVEF <35% as measured by CMR related to a poor prognosis in patients with pulmonary arterial hypertension (8) . We excluded all patients with pacemakers, poor quality ECG, left bundle branch blocks and those without measurable pulmonary artery mean pressure by catheterization and RVEF by CMR. The ethics committee of Keio University Hospital approved this study and a signed informed consent was obtained from each patient before participation.
Right heart catheterization
All PH patients underwent right heart catheterization, during which right atrial pressure, right ventricular pressure, pulmonary artery pressure, pulmonary capillary wedge pressure, and mixed venous oxygen saturation were measured. Cardiac output was calculated using Fick's principle. Oxygen consumption was measured during right heart catheterization. Pulmonary vascular resistance was calculated by dividing the transpulmonary gradient (pressure difference between mean pulmonary artery pressure and pulmonary capillary wedge pressure) by cardiac output.
ECG
The ECG (Fukuda Denshi, Tokyo, Japan) was performed by trained technicians and reviewed by 2 independent cardiologists (Kappa statics =0.86) who were also blinded to the CMR results and the patients' symptoms. The ECG calibration was 25 mm/s and 10 mm/mV. We elected to study the following ECG patterns of RVH as proposed by 2 previous studies (6, 7): R wave in lead V1>0.7 mV, S wave in lead V1 0.2 mV, S wave in lead V5>0.7 mV, sum of R wave in lead V1 and S wave in lead V5>1.05 mV, R wave in lead V5<0.5 mV, R wave to S wave ratio (R/S) in lead V5<1, R wave in lead aVR>0.5 mV, R/S in lead V5 divided by R/S in lead V1<0.4, R/S in lead V1>0.5, presence of qR in lead V1, negative T wave in lead V1 in the presence of R wave >0.5 mV, and right axis deviation >110 degrees.
CMR
CMR images were obtained using a 1.5-Tesla clinical scanner (GE). For RV volume measurements, contiguous transverse images were acquired through the entire RV using a 2D cine, steady-state, free precession technique with prospective electrocardiographic gating (Fig. 1) . Each crosssectional image was obtained in a single breath-hold with the following parameters: repetition time, 3.2 ms; echo time, 1.6 ms; flip angle, 45°; bandwidth, 125 kHz; field of view, (9) . The endocardial borders of all images at end-diastole and end-systole were manually traced by a radiologist with 10 years' CMR experience, as previously reported (9). The end-diastolic volume, end-systolic volume, and ejection fraction were automatically calculated using Simpson's rule. Inclusion of the trabeculae carneae in the RV volume was the same as that used in the ultrasonography methods for comparison. A time period of less than 15 minutes was required for obtaining the RV volume measurement.
Statistical analyses
All statistical analyses were performed using SPSS 15.0 (Chicago, IL, USA). Continuous data were expressed as the mean ± SD. The 2 groups were compared using the unpaired t-test or the nonparametric means test for continuous variables. Categorical variables were reported as frequencies with percentages and compared between the 2 groups using the chi-square test. Univariate and multivariate logistic regression analyses were used to assess the effects of various factors on the RVSD determinant. A 2-sided 5% level of significance was considered significant for all of the statistical tests. Statistical significance was defined as p<0.05. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated using standard formulas.
Results
Patient characteristics
The clinical characteristics of the patients with PH according to the presence or absence of RVSD are summarized in Table 1 . The RVSD group had significantly higher proportions of patients with elevated plasma B-type natriuretic peptide (BNP) levels, pulmonary vascular resistance, and decreased cardiac output (CO) compared to the non-RVSD group. There were no significant differences in age, gender, or mean right atrial pressure, right ventricular enddiastolic pressure, or mean pulmonary artery pressure measured by right heart catheterization between the two groups.
CMR findings
Ventricular volume and systolic function of the patients with or without RVSD are presented in Table 2 . RV end systolic volume was significantly increased and RVEF was depressed in the RVSD group compared with non-RVSD group. However, there were no significant differences in RV end diastolic dimension in patients with or without RVSD.
ECG findings for determinants of RVSD
Of the ECG findings, absolute voltage of R wave and S wave, R/S in lead V1, degree of right axis deviation (RAD), and the prevalence of the qR pattern in lead V1 were significantly higher in the RVSD group compared with non-RVSD group (Table 3) . In univariate logistic regression analysis, variables that predicted RVSD were qR patterns in lead V1, R/S in lead V1>1, S wave in lead V1<0.2 mV, BNP >100 pg/ mL, and CO <3.0 L/min. Furthermore, multivariate logistic regression analysis related to ECG findings showed the presence of qR patterns in lead V1 to be an independent predictive factor of RVSD (Table 4) . Table 5 shows the sensitivity, specificity, PPV, and NPV of the ECG findings for determinants of RVSD in patients with PH. The presence of the qR pattern in lead V1 showed a high specificity (87.5%) and PPV (83.3%), and R/S>1 in lead V1 showed a high sensitivity (93.3%) and NPV (90%). When these parameters were combined, the presence of the qR pattern in lead V1 and R/S>1 in lead V1 had better specificity (93.8%) and PPV (90%) than did any individual RVH criterion.
We also performed the same analyses in the IPAH and CTEPH sub-groups and obtained similar results in IPAH group (Table 4, 5) , however, no significant results were obtained in CTEPH group (data not shown).
ECG scoring system and its association with RVSD
The presence of qR in lead V1 and R/S>1 in lead V1 were significant predictors of RVSD, and each of these ECG findings was assigned to have points proportional to their odds ratio (score of 2 for the presence of qR pattern in lead V1, and score of 1 for R/S>1 in lead V1). As demonstrated in Fig. 2 , the percentage of RVSD was increased along with the total ECG score.
Discussion
In the current study, we demonstrated that the ECG findings related to RVH criteria, especially in lead V1, predicted the presence of RVSD defined by CMR in patients with PH, and that the cumulative score further improves its predictability. These findings suggest that ECG may be a useful clinical tool to supplement the prediction of RVSD, and it may provide important information about the indication of CMR for the assessment of RVSD in patients with PH.
Generally, in the setting of PH, RV is exposed to chronic pressure overload. An initial adaptive response of RV hypertrophy is followed by progressive contractile dysfunction (10) . Chamber dilatation ensues to allow compensatory preload and maintain stroke volume despite reduced fractional shortening. As contractile weakening progresses, clinical evidence of decompensated RV failure occurs, characterized by rising filling pressures, diastolic dysfunction (11), and diminishing CO, which is compounded by tricuspid regurgitation due to annular dilatation and poor leaflet coaptation. The increased size and pressure overload of the RV also produce diastolic dysfunction of the left ventricle (12) .
The presence of RVSD is a well-known predictor of prognosis in patients with PH. In 1991, the National Prospective Registry demonstrated that mortality in primary PH appears to correlate best with RV hemodynamic function (1). Furthermore, McLaughlin et al. suggested that mean pulmonary artery pressure may not be the most direct indicator of disease severity, and that treatment outcome might be better assessed using other indicators of RV function such as cardiac index and right atrial pressure (13) . The degree of tricuspid regurgitation may also be a marker of RV failure in patients with pulmonary hypertension since it correlates modestly with right atrial size, RV diastolic dimension, and tricuspid annulus diameter (14) . These studies suggested that RV size was also an important indicator of PH severity and chronic status in addition to RV function. The measurement of RV function is crucial for the management of PH; however, it is challenging for many reasons, partially because of the interplay between intrinsic myocardial performance and RV loading conditions. Although RVSD has been reported to be associated with clinical deterioration and mortality in heart failure or PH, the extent to which any of these parameters is useful as an outcome measure in clinical research or practice remains unclear (15) . In clinical practice, ECG is easily accessible, and ECG interpretation skills can be easily acquired and are usually incorporated in basic physician training. Competent ECG performance and interpretation is not always easily accessible. If validated as a good clinical tool with acceptable PPV for significant PH, ECG may guide clinicians in selecting appropriate patients for further testing.
Al-Naamani et al. demonstrated that these ECG patterns Figure 2 . Electrocardiography score for predicting right ventricular systolic dysfunction in patients with pulmonary hypertension. Both the presence of qR in lead V1 and R to S wave ratio (R/S) >1 in lead V1 were assigned a number of points proportional to the odds ratio in univariate analysis. A score of 2 was assigned to the presence of qR in lead V1, while a score of 1 was assigned to R/S >1 in lead V1. The percentage of RVSD was increased along with the total ECG score.
had superior PPVs for PH: R wave in the I lead <0.2 mV, S wave in lead V1<0.2 mV, R/S in lead V1>1, R/S in lead V6>1, RAD >110 degrees, and the presence of the qR pattern in lead V1 (16) . In the present study, among these variables, we found that the presence of the qR pattern in lead V1 and R/S>1 in lead V1 were significant PPV findings of RVSD. Furthermore, the combined criteria of 2 key variables had better specificity and PPV than did any individual criterion alone. In the current study, the presence of the qR pattern in lead V1 remained as an independent determinant of RVSD after adjustment. There were a few studies on the prognostic role of the presence of the qR pattern in lead V1 in primary PH. In 1981, Kanemoto reported that in 86 patients with PPH before epoprostenol treatment, the incidence of the qR pattern in lead V1 was significantly higher in the deceased patients (42.1%) than in the surviving patients (21.6%) (17) . Bossone et al. showed that the presence of the qR pattern in lead V1 was highly predictive of an adverse outcome (18).
Study limitations
There were several limitations in our study. First, we were able to enroll only 31 patients because PH, which is not caused by left ventricular failure, is a relatively rare disorder. We found that the combination of qR pattern and R/S ratio in lead V1 was useful for predicting RVSD in patients with PH. However, the clinical value of these ECG findings needs to be evaluated in a large clinical study. Second, although there are important parameters, such as RV size, RV wall thickness and tricuspid annular plane systolic excursion (TAPSE) measured by echocardiogram for the evaluation of RV remodeling and function in addition to CMR (19) , these parameters were not measured. Finally, the mechanisms of the differences among etiology of PH are still unclear. However, the number of patients except for IPAH is insufficient for evaluating the relationship between ECG findings and RVSD, further study including groups 1 through 4 in the updated classification (20) is warranted.
Conclusion
The combination of 2 findings in lead V1 of ECG-RVH criteria predicts the presence of RVSD defined by CMR in patients with PH. The findings suggest that ECG might be a useful tool for estimating the presence of RVSD along with the echocardiogram.
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